home / stock / rhhby / rhhby quote
Last: | $31.92 |
---|---|
Change Percent: | 0.0% |
Open: | $31.53 |
Close: | $31.92 |
High: | $31.95 |
Low: | $31.53 |
Volume: | 1,828,049 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$31.92 | $31.53 | $31.92 | $31.95 | $31.53 | 1,828,049 | 03-29-2024 |
$31.92 | $31.53 | $31.92 | $31.95 | $31.53 | 1,823,544 | 03-28-2024 |
$31.31 | $31.16 | $31.31 | $31.38 | $31.13 | 1,650,410 | 03-27-2024 |
$31.31 | $31.38 | $31.31 | $31.47 | $31.3 | 1,905,466 | 03-26-2024 |
$31.29 | $31.34 | $31.29 | $31.47 | $31.29 | 1,477,652 | 03-25-2024 |
$31.32 | $31.58 | $31.32 | $31.61 | $31.26 | 2,341,008 | 03-22-2024 |
$31.32 | $31.36 | $31.32 | $31.5 | $31.16 | 2,409,639 | 03-21-2024 |
$32.62 | $32.41 | $32.62 | $32.8 | $32.31 | 1,033,237 | 03-20-2024 |
$32.12 | $32.2 | $32.12 | $32.3 | $32.08 | 1,954,099 | 03-19-2024 |
$32.18 | $32.39 | $32.18 | $32.45 | $32.15 | 1,427,900 | 03-18-2024 |
$32.64 | $32.85 | $32.64 | $32.93 | $32.59 | 735,015 | 03-15-2024 |
$32.89 | $33.005 | $32.89 | $33.09 | $32.66 | 4,437,724 | 03-14-2024 |
$34.22 | $34.69 | $34.22 | $34.83 | $34.07 | 1,756,718 | 03-13-2024 |
$35.15 | $34.65 | $35.15 | $35.21 | $34.61 | 1,189,377 | 03-12-2024 |
$34.61 | $34.26 | $34.61 | $34.67 | $34.22 | 1,458,765 | 03-11-2024 |
$33.9 | $33.86 | $33.9 | $33.965 | $33.77 | 802,508 | 03-08-2024 |
$33.77 | $33.82 | $33.77 | $33.82 | $33.62 | 1,082,701 | 03-07-2024 |
$33.47 | $33.31 | $33.47 | $33.5 | $33.27 | 1,379,402 | 03-06-2024 |
$33.15 | $33.21 | $33.15 | $33.324 | $33.11 | 768,642 | 03-05-2024 |
$32.88 | $32.81 | $32.88 | $33 | $32.8 | 979,795 | 03-04-2024 |
News, Short Squeeze, Breakout and More Instantly...
Roche Holding Ltd ADR Company Name:
RHHBY Stock Symbol:
OTCMKTS Market:
Thursday, Argenx SE (NASDAQ:ARGX) shares are trading higher in reaction to Chugai Pharmaceutical Co Ltd’s disappointing g...
Wednesday, Roche Holding AG (OTC:RHHBY) entered into a definitive agreement with Lonza Group Ltd (OTC:LZAGF) (OTC:LZAGY). Under...
On Thursday, the FDA approved BeiGene Ltd’s (NASDAQ:BGNE) approved Tevimbra (tislelizumab-jsgr) as monotherapy for adult patients w...